It found that only 11% of patients receiving Dex developed cerebral hyperperfusion, compared to 38% in a placebo group. Only 3% of patients went on to develop cerebral hyperperfusion syndrome, ...

Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, ...

TPU-006 is an investigational 4-day dexmedetomidine transdermal system, a novel drug delivery technology with a non-opioid active moiety for managing post-surgical pain. "We are excited by the FDA ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some ...

Study Selection and Data Extraction: Studies that focused on the safety and efficacy of clonidine and dexmedetomidine in both animals and humans were selected. Conclusion: Clonidine and ...